Key facts
- Halozyme CEO Helen Torley sold $3.37 million in shares.
- The sale occurred after the exercise of stock options.
Halozyme CEO Helen Torley has sold $3.37 million worth of the company's shares. This transaction took place after she exercised her stock options. The sale represents a significant divestment by the company's chief executive.